OmniStar Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.3M | Buy |
1,120
+936
| +509% | +$1.1M | 0.56% | 55 |
|
|
2026
Q2 | $221K | Buy |
+184
| New | +$188K | 0.1% | 108 |
|
|
2026
Q1 | – | Sell |
-379
| Closed | -$408K | – | 129 |
|
|
2025
Q4 | $408K | Buy |
+379
| New | +$362K | 0.24% | 81 |
|
|
2025
Q3 | – | Sell |
-482
| Closed | -$376K | – | 132 |
|
|
2025
Q2 | $376K | Buy |
+482
| New | +$375K | 0.28% | 88 |
|
|
2025
Q1 | – | Sell |
-656
| Closed | -$507K | – | 141 |
|
|
2024
Q4 | $507K | Sell |
656
-22
| -3% | -$18.2K | 0.41% | 80 |
|
|
2024
Q3 | $602K | Buy |
678
+412
| +155% | +$370K | 0.45% | 92 |
|
|
2024
Q2 | $241K | Buy |
266
+1
| +0.4% | +$800 | 0.22% | 110 |
|
|
2024
Q1 | $206K | Buy |
+265
| New | +$189K | 0.19% | 112 |
|
|
2023
Q1 | – | Sell |
-645
| Closed | -$236K | – | 114 |
|
|
2022
Q4 | $236K | Sell |
645
-866
| -57% | -$307K | 0.27% | 97 |
|
|
2022
Q3 | $488K | Sell |
1,511
-325
| -18% | -$103K | 0.58% | 71 |
|
|
2022
Q2 | $595K | Sell |
1,836
-90
| -5% | -$27K | 0.66% | 57 |
|
|
2022
Q1 | $551K | Sell |
1,926
-600
| -24% | -$154K | 0.55% | 71 |
|
|
2021
Q4 | $697K | Buy |
2,526
+2,426
| +2,426% | +$615K | 0.71% | 59 |
|
|
2021
Q3 | $573K | Buy |
+100
| New | +$24.7K | 0.68% | 60 |
|
|
2021
Q2 | – | Sell |
-3,951
| Closed | -$794K | – | 143 |
|
|
2021
Q1 | $738K | Sell |
3,951
-1,887
| -32% | -$369K | 0.94% | 41 |
|
|
2020
Q4 | $986K | Buy |
5,838
+1,263
| +28% | +$189K | 0.69% | 53 |
|
|
2020
Q3 | $677K | Sell |
4,575
-512
| -10% | -$79.2K | 0.51% | 61 |
|
|
2020
Q2 | $835K | Sell |
5,087
-482
| -9% | -$74K | 0.69% | 56 |
|
|
2020
Q1 | $773K | Sell |
5,569
-2,474
| -31% | -$340K | 0.76% | 47 |
|
|
2019
Q4 | $1.06M | Buy |
8,043
+2,405
| +43% | +$279K | 0.89% | 43 |
|
|
2019
Q3 | $631K | Buy |
5,638
+518
| +10% | +$57.7K | 0.55% | 65 |
|
|
2019
Q2 | $567K | Sell |
5,120
-400
| -7% | -$47.1K | 0.51% | 70 |
|
|
2019
Q1 | $716K | Sell |
5,520
-13,525
| -71% | -$1.64M | 0.63% | 59 |
|
|
2018
Q4 | $2.2M | Sell |
19,045
-15,912
| -46% | -$1.78M | 2.25% | 8 |
|
|
2018
Q3 | $3.75M | Sell |
34,957
-645
| -2% | -$64.5K | 2.86% | 1 |
|
|
2018
Q2 | $3.04M | Buy |
35,602
+14,070
| +65% | +$1.16M | 2.89% | 2 |
|
|
2018
Q1 | $1.66M | Buy |
21,532
+577
| +3% | +$46.5K | 1.59% | 25 |
|
|
2017
Q4 | $1.77M | Buy |
+20,955
| New | +$1.78M | 1.62% | 22 |
|
Other funds holding LLY
OmniStar Financial Group's LLY Position: Q3 2026 in Review
OmniStar Financial Group increased its Eli Lilly (LLY) stake by 509% in Q3 2026, buying an estimated $1.1M and bringing the position to 1,120 shares worth $1.3M. The position accounts for 0.56% of the portfolio, ranked #55.
OmniStar Financial Group first reported a position in LLY in Q4 2017 and has held it in 28 quarters since. The position peaked at $3.75M in Q3 2018. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- OmniStar Financial Group held 1,120 shares of Eli Lilly worth $1.3M as of Q3 2026.
- OmniStar Financial Group bought 936 Eli Lilly shares in Q3 2026, an estimated $1.1M.
- Eli Lilly made up 0.56% of OmniStar Financial Group's portfolio in Q3 2026, its #55 holding.
- OmniStar Financial Group first reported a position in Eli Lilly in Q4 2017 and has held it in 28 quarters since.
- OmniStar Financial Group's Eli Lilly position peaked at $3.75M in Q3 2018.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on OmniStar Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.